Ilmenauer Discovery Tool

1

Cover Image

A Phase II Study of Talazoparib (BMN 673) in Patients With Homologous Recombination Repair Deficiency Positive Stage IV Squamous Cell Lung Cancer (Lung-Map Sub-Study)

Published August 31, 2018

Subjects: “...misc BARD1 Gene Mutation...”
eBook

2

Cover Image

A Phase 1b Biomarker-Driven Combination Trial of Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors

Published March 29, 2019

Subjects: “...misc BARD1 Gene Mutation...”
eBook

3

Cover Image

A Phase II Study of Olaparib (AZD2281) in Patients With Metastatic/Advanced Urothelial Carcinoma With DNA-Repair Defects

Published March 15, 2019

Subjects: “...misc BARD1 Gene Mutation...”
eBook